{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T05:45:22Z","timestamp":1774849522881,"version":"3.50.1"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetic peripheral neuropathy (DPN) is a common disabling complication of type 2 diabetes (T2D), yet the contribution of systemic arterial stenosis to electrophysiological nerve dysfunction remains incompletely characterized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine whether carotid arterial stenosis (CASD) and lower-limb arterial stenosis (LWASD) are associated with multi-nerve conduction abnormalities in T2D, and to explore supportive molecular signatures using transcriptomic analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective cross-sectional study, 202 patients with T2D underwent bilateral carotid and lower-limb ultrasonography and standardized nerve conduction testing. Nerve dysfunction was quantified using 16 binary electrophysiological abnormality indicators. Generalized estimating equation (GEE) models estimated marginal associations between stenosis grades and nerve abnormality, adjusting for age and sex, with an expanded model additionally adjusting for HbA1c, LDL-cholesterol, and triglycerides to assess robustness to metabolic confounding. Patient-level abnormality burden was evaluated using a binomial model (abnormal indicators out of those assessed). Transcriptomic differential expression and pathway enrichment were performed using the public microarray dataset GSE95849 to provide supportive systemic molecular context.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>LWASD was significantly associated with increased odds of nerve conduction abnormality and remained robust after metabolic adjustment (OR \u2248 1.5 per grade increase, p&amp;lt; 0.001), whereas CASD showed weaker and non-significant associations in the primary nerve-level models. Nerve-specific analyses suggested stronger signals in distal lower-limb measures consistent with a length-dependent pattern. Transcriptomic analyses highlighted enrichment of pathways related to hypoxia responses, inflammatory signaling, mitochondrial dysfunction, and neuronal maintenance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Lower-limb arterial stenosis is independently associated with a greater burden of electrophysiological nerve abnormalities in T2D beyond key metabolic parameters. Transcriptomic signatures support a vascular\u2013hypoxic\u2013inflammatory context consistent with mechanisms implicated in diabetic complications; however, causal direction cannot be inferred from cross-sectional data.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1758863","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T04:13:15Z","timestamp":1774843995000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Arterial stenosis and electrophysiological nerve dysfunction in type 2 diabetes: clinical evidence from GEE models and transcriptomic pathway analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Xiu-qin","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Neurology, Jinshan Hospital Affiliated to Fudan University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei-jun","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Echocardiography, Jinshan Hospital Affiliated to Fudan University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Jinshan Hospital Affiliated to Fudan University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-chen","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Neurology, Jinshan Hospital Affiliated to Fudan University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng-bing","family":"Zu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Jinshan Hospital Affiliated to Fudan University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-feng","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Jinshan Hospital Affiliated to Fudan University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-feng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Jinshan Hospital Affiliated to Fudan University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.2337\/dc10-2222","article-title":"Diabetic peripheral neuropathy is associated with increased arterial stiffness without changes in carotid intima\u2013media thickness in type 2 diabetes","volume":"34","author":"Kim","year":"2011","journal-title":"Diabetes Care"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-014-0473-5","article-title":"Diabetic neuropathy: mechanisms, emerging treatments,\u00a0and subtypes","volume":"14","author":"Albers","year":"2014","journal-title":"Curr Neurol Neurosci Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1210\/jc.2016-2030","article-title":"Endothelial Dysfunction as a Link Between Cardiovascular Risk Factors and Peripheral Neuropathy in Diabetes","volume":"101","author":"Roustit","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01400-z","article-title":"Diabetic vascular diseases: molecular mechanisms and therapeutic strategies","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transd Targ Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2019.12.153","article-title":"Diabetes and carotid artery disease: a narrative review","volume":"8","author":"Katsiki","year":"2020","journal-title":"Ann Trans Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13072141","article-title":"Peripheral Arterial Disease and the Diabetic Foot Syndrome: Neuropathy Makes the Difference! A Narrative Review","volume":"13","author":"R\u00fcmenapf","year":"2024","journal-title":"J Clin Med"},{"key":"B7","article-title":"Correlation between diabetic lower-extremity arterial disease and diabetic neuropathy in patients with type II diabetes: An exploratory study","volume":"8","author":"Sun","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.824215","article-title":"Risk factors for diabetic peripheral neuropathy, peripheral artery disease, and foot deformity among the population with diabetes in Beijing, China: a multicenter, cross-sectional study","volume":"13","author":"Liu","year":"2022","journal-title":"Front Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00125-021-05380-z","article-title":"Hypoxia and hypoxia-inducible factors in diabetes and its complications","volume":"64","author":"Catrina","year":"2021","journal-title":"Diabetologia"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1265372","article-title":"Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment","volume":"14","author":"Zhu","year":"2024","journal-title":"Front Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14171922","article-title":"The association between the severity of distal sensorimotor polyneuropathy and increased carotid atherosclerosis in individuals with type 2 diabetes","volume":"14","author":"Hsieh","year":"2024","journal-title":"Diagnostics"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v12.i6.827","article-title":"Diabetes and peripheral artery disease: a review","volume":"12","author":"Soyoye","year":"2021","journal-title":"World J Diabetes"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1007\/s001250100001","article-title":"Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy","volume":"44","author":"Cameron","year":"2001","journal-title":"Diabetologia"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14477","article-title":"How inflammation dictates\u00a0diabetic peripheral neuropathy: an enlightening review","volume":"30","author":"Cheng","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1007\/s00125-011-2191-8","article-title":"Regulation of hypoxia-inducible factor 1 and the loss of the cellular response to hypoxia in diabetes","volume":"54","author":"Bento","year":"2011","journal-title":"Diabetologia"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.47525","article-title":"A comprehensive review of the vascular consequences of diabetes in the lower extremities: current approaches to management and evaluation of clinical outcomes","volume":"15","author":"Yachmaneni","year":"2023","journal-title":"Cureus"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.01038","article-title":"Functional and structural changes of the blood-nerve-barrier in diabetic neuropathy","volume":"12","author":"Richner","year":"2019","journal-title":"Front Neurosci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"542","DOI":"10.4093\/dmj.2025.0299","article-title":"Clinical phenotypes of diabetic peripheral neuropathy: implications for phenotypic-based therapeutics strategies","volume":"49","author":"Lee","year":"2025","journal-title":"Diabetes Metab J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s00109-018-1707-9","article-title":"Hypoxia-inducible factor 1\u03b1 protects peripheral sensory neurons from diabetic peripheral neuropathy by suppressing accumulation of reactive oxygen species","volume":"96","author":"Rojas","year":"2018","journal-title":"J Mol Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1758863\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T04:13:20Z","timestamp":1774844000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1758863\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":19,"alternative-id":["10.3389\/fendo.2026.1758863"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1758863","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"article-number":"1758863"}}